PT  - JOURNAL ARTICLE
AU  - Bazant, Martin Z.
AU  - Bush, John W. M.
TI  - Beyond Six Feet: A Guideline to Limit Indoor Airborne Transmission of COVID-19
AID  - 10.1101/2020.08.26.20182824
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.26.20182824
4099  - http://medrxiv.org/content/early/2020/09/01/2020.08.26.20182824.short
4100  - http://medrxiv.org/content/early/2020/09/01/2020.08.26.20182824.full
AB  - The revival of the world’s economy is being predicated on the Six-Foot Rule, a guideline that offers little protection from pathogen-bearing droplets sufficiently small to be continuously mixed through an indoor space. The importance of indoor, airborne transmission of COVID-19 is now widely recognized; nevertheless, no quantitative measures have been proposed to protect against it. In this article, we build upon models of airborne disease transmission in order to derive a safety guideline that would impose a precise upper bound on the “cumulative exposure time”, the product of the number of occupants and their time in an enclosed space. We demonstrate the manner in which this bound depends on the ventilation rate and dimensions of the room; the breathing rate, respiratory activity and face-mask use of its occupants; and the infectiousness of the respiratory aerosols, a disease-specific parameter that we estimate from available data. Case studies are presented, implications for contact tracing considered, and appropriate caveats enumerated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We confirm that all ethical guidelines have been followed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAn Excel spreadsheet is provided as a supplementary file to calculate our COVID-19 safety guideline for a specific indoor space. Expiratory aerosol droplet size distributions were taken from the cited literature, as either provided by the authors (Asadi et al, 2020) or digitally scanned from published figures (Morawska et al, 2009).